Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

NCT00556413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: oxaliplatin

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle